ClinicalTrials.gg
Drug

Modafinil clinical trials

Also written Provigil, Nuvigil and CEP-10953.

studies test it
187
open now
10
in phase 3
50
first study started
1997

How each study uses Modafinil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Modafinil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Dec 1998 · PROVIGIL · NDA 020717 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Modafinil
109
Armodafinil
46
Modafinil 200mg
4
Armodafinil 150 mg/day
4
R-modafinil
3

Brand

Provigil
50
Nuvigil
28
PROVIGIL 200 mg
1

Development codes

CEP-10953
9

Studies by the year they started

186 studies that test it; most in 2006 (16)

Studies that test Modafinil, by start year
YearStudies
19971
20011
20026
200313
200415
200514
200616
200710
200816
200916
201015
201115
20124
20137
20147
20163
20174
20186
20191
20221
20232
20243
20253
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
27
Phase 2
65
Phase 3
50
Phase 4
29
No phase
26

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 38 · Other 149

Cephalon (27) · M.D. Anderson Cancer Center (7) · University of Arkansas (5) · Duke University (4) · The University of Texas Health Science Center, Houston (4) · New York State Psychiatric Institute (4) · National Institute on Drug Abuse (NIDA) (4) · Yale University (3)

Often tested with

Tested in the same studies.

Methylphenidate (10) · Minocycline (4) · Propranolol (3) · Caffeine (3) · Acetazolamide (2) · Atomoxetine (2) · Indomethacin (2) · Melatonin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 2 in phase 3

Studies that test Modafinil, phase 3 first.

Studies

Open first, then newest update. How each study uses Modafinil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 187

See all 187 studies that test Modafinil →

Given beside what is tested · 10 — Modafinil is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Modafinil

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call Modafinil · ClinicalTrials.gg INT006717

  • MeSH (NLM) D000077408ModafinilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) R3UK8X3U3DMODAFINILConfirmed FDA, NLM, Wikidata
  • RxNorm 30125Confirmed FDA, Wikidata
  • Wikidata Q410441modafinilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C26661ModafinilOne source FDA
  • DrugBank DB00745One source Wikidata

Also registered as armodafinil (UNII V63XWA605I · RxNorm 641465).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.